本頁面由Tiger Trade Technology Pte. Ltd.提供服務

NEWAMSTERDAM PHARMA CO NV

21.76
+0.60002.84%
成交量:26.10萬
成交額:572.92萬
市值:26.01億
市盈率:-10.15
高:22.15
開:22.07
低:21.59
收:21.16
52周最高:42.21
52周最低:21.08
股本:1.20億
流通股本:9,251.29萬
量比:2.56
換手率:0.28%
股息:- -
股息率:- -
每股收益(TTM):-2.1442
每股收益(LYR):-1.7211
淨資產收益率:-36.81%
總資產收益率:-20.11%
市淨率:4.12
市盈率(LYR):-12.64

資料載入中...

2024/05/09

重要事件披露

Form 8-K - Current report
2024/05/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/01

重要事件披露

Form 8-K - Current report
2024/03/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/04

重要事件披露

Form 8-K - Current report
2024/03/01

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/28

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/21

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/15

重要事件披露

Form 8-K - Current report
2024/02/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/22

重要事件披露

Form 8-K - Current report
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/04

重要事件披露

Form 8-K - Current report
2023/12/16

SEC問詢函

Form CORRESP - Correspondence
2023/09/20

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/08/15

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/01

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/07/07

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership